Select Publications
Journal articles
2004, 'Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction', Journal of Molecular and Cellular Cardiology, 37, pp. 979 - 987
,2004, 'Involvement of chymase-mediated angiotensin II generation in blood pressure regulation', Journal of Clinical Investigation, 114, pp. 112 - 120
,2004, 'Phospholipase C-[delta]1 rescues intracellular Ca2+ overload in ischemic heart and hypoxic neonatal cardiomyocytes', Journal of Steroid Biochemistry and Molecular Biology, 91, pp. 131 - 138, http://www.sciencedirect.com/science/article/B6T8X-4CSYKH2-1/2/ddae75a5eacab1a819c826961b301a29
,2004, 'Stem-cell therapy for myocardial diseases', The Lancet, 363, pp. 1735 - 1736, http://www.sciencedirect.com/science/article/B6T1B-4CF51H5-16/2/5af11943dcf04c84ca831fb4b99586df
,2003, 'IGF-1 Enhances a Store-Operated Ca2+ Channel in Skeletal Muscle Myoblasts: Involvement of a CD20-Like Protein', Journal of Cellular Physiology, 197, pp. 53 - 60, http://dx.doi.org/10.1002/jcp.10347
,2003, 'Allosteric á1-adrenoceptor antagonism by the conopeptide ñ-TIA', The Journal of Biological Chemistry, 278, pp. 34451 - 34457, http://dx.doi.org/10.1074/jbc.M305410200
,2003, 'Cardiac-targeted overexpression of the α1A-AR results in premature death: A potential model of electromechanical dissociation', Heart, Lung and Circulation, 12, pp. A59 - A59, http://dx.doi.org/10.1046/j.1443-9506.2003.02393.x
,2003, 'Dissecting cardiac hypertrophy and signalling pathways: evidence for an interaction between multifunctional G proteins and prostanoids', Corc Res, 92, pp. 1059 - 1061
,2003, 'Distinct transglutaminase II/TG2-independent and TG2-dependent pathways mediate articular chondrocyte hypertrophy', The Journal of Biological Chemistry, 21, pp. 18824 - 18832
,2003, 'Do studies with ACE N- and C-Fomain-Selective Inhibitors provide evidence for a non-ACE, non-chymase Angiotensin II-forming pathway?', Circ Res, 93, pp. 91 - 93
,2003, 'Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases', Proceedings of the National Academy of Sciences of the United States of America, 22, pp. 12636 - 12641
,2003, 'IGF-1 enhances store-operated Ca2+ channel activity in skeletal myoblasts : possible involvement of a CD20-like protein', Journal of Cell Physiol, 197, pp. 53 - 60
,2003, 'Structural details (kinks and non-a-helical conformations) in transmembrane helices are intrahelically determined and can be predicted by sequence pattern descriptors.', Nucleic Acids Research, 15, pp. 4625 - 4631
,2003, 'Transglutaminases: crosslinking enzymes with pleiotropic functions.', Nature Reviews Molecular Cell Biology, 4, pp. 140 - 156
,2003, 'Validity of mouse models for the study of tissue transglutaminase in neurodegenerative diseases', Molecular and Cellular Neuroscience, 25, pp. 493 - 503
,2002, 'New pharmacotherapies for alcohol dependence', Medical Journal of Australia, 177, pp. 103 - 107, http://dx.doi.org/10.5694/j.1326-5377.2002.tb04683.x
,2002, 'Keratosis pilaris atrophicans in mother and daughter', Journal of the European Academy of Dermatology and Venereology, 16, pp. 397 - 400, http://dx.doi.org/10.1046/j.1468-3083.2002.00472.x
,2002, 'Mutation of a single TMVI residue, Phe282, in the β
2002, 'Identification of distinct domains reciprocally regulating subtype-specific differences in [alpha](1)-adrenergic receptor phosphorylation and internalisation', FASEB JOURNAL, 16, pp. A564 - A564, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000174533603134&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2002, 'Phe303 in TMVI of the α
2002, 'Molecular mechanisms of inherited cardiomyopathies', Physiological Reviews, 82, pp. 945 - 980, http://dx.doi.org/10.1152/physrev.00012.2002
,2002, 'Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol)', Current Pharmaceutical Design, 8, pp. 1063 - 1075
,2002, 'Conserved tryptophan in the core domain of transglutaminase is essential for catalytic activity.', Proceedings of the National Academy of Sciences of the United States of America, 99, pp. 2738 - 2742
,2001, 'Identification of Phe303 in transmembrane segment VI of the alpha1B-adrenergic receptor as a key switch residue for isomerization of receptor to multiple conformers', FASEB JOURNAL, 15, pp. A220 - A220, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000167438101258&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2001, 'Mutations of a single TMVI residue, Phe282, in the beta2-adrenergic receptor result in structurally distinct activated receptor-conformations.', FASEB JOURNAL, 15, pp. A220 - A220, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000167438101255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2001, 'Non-α-helical elements modulate polytopic membrane protein architecture', Journal of Molecular Biology, 306, pp. 349 - 362, http://dx.doi.org/10.1006/jmbi.2000.4402
,2001, 'Prognostic value of left ventricular hypertrophy in hypertrophic cardiomyopathy', New England Journal of Medicine, 344, pp. 63 - 65, http://dx.doi.org/10.1056/NEJM200101043440115
,2001, 'Non-a-helical elements drive diversity of polytopic membrane protein architecture', Journal of Molecular Biology, pp. 349 - 362
,2001, 'Phe303 in transmembrane segment VI of the a1B-adrenergic receptor is a key switchresidue coupling transmembrane helical movements to G protein activation', Biochemistry, pp. 588 - 596
,2001, 'Targeted a1A-Adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy.', Circ Res, pp. 343 - 350
,2001, 'Targeted inactivation of Gh/tissue transglutaminase II', The Journal of Biological Chemistry, pp. 20673 - 20678
,2001, 'Targeted inactivation of Gh/Transglutaminase II', The Journal of Biological Chemistry, pp. 20673 - 20678
,2000, 'Dominant-negative activity of an α(1β)-adrenergic receptor signal-inactivating point mutation', EMBO Journal, 19, pp. 4265 - 4271
,2000, 'Acne keloidalis in caucasian patients on cyclosporin following organ transplantation [15]', British Journal of Dermatology, 143, pp. 465 - 466, http://dx.doi.org/10.1046/j.1365-2133.2000.03694.x
,2000, 'Pulsed-field gel electrophoresis of degradation-sensitive DNAs from Clostridium difficile PCR ribotype 1 strains', Journal of Clinical Microbiology, 38, pp. 2791 - 2792, http://dx.doi.org/10.1128/jcm.38.7.2791-2792.2000
,2000, 'Spurious systolic hypertension in youth', Vascular Medicine, 5, pp. 141 - 145, http://dx.doi.org/10.1177/1358836x0000500303
,2000, 'GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket.', The Journal of Biological Chemistry, 275, pp. 18259 - 18265
,1999, 'Skeletal muscle hypertrophy involves a Ca2+/calcineurin/NF-AT2/c-dependent signalling pathway.', CIRCULATION, 100, pp. 354 - 354, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000083417101857&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1999, 'Phe310 in transmembrane VI of the α(1B)-adrenergic receptor is a key switch residue involved in activation and catecholamine ring aromatic bonding', Journal of Biological Chemistry, 274, pp. 16320 - 16330, http://dx.doi.org/10.1074/jbc.274.23.16320
,1999, 'Insulin-like growth facor (IGF-1) induces myotube hypertrophy associated with an increase in anaerobic glycolysis in skeletal muscle cell model', Biochemical Journal, pp. 443 - 451
,1999, 'Organisation and chromosomal mapping of mouse Gh/tissue transglutaminase gene (Tgm2)', Archives of Biochemistry and Biophysics, 366, pp. 151 - 156
,1999, 'Pathogenesis of inherited forms of dilated cardiomyopathy', New England Journal of Medicine, pp. 1759 - 1762
,1999, 'Phe310 in Transmembrane VI of the alpha1B-adrenergic receptor is a key switch residue involved in activation and catecholamine ring aromatic bonding', The Journal of Biological Chemistry, pp. 16320 - 16330
,1999, 'Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway', Nature, pp. 576 - 581
,1998, 'Release of the neuregulin functional polypeptide requires its cytoplasmic tail', Journal of Biological Chemistry, 273, pp. 34335 - 34340, http://dx.doi.org/10.1074/jbc.273.51.34335
,1998, 'Homozygous variegate porphyria: Identification of mutations on both alleles of the protoporphyrinogen oxidase gene in a severely affected proband', Journal of Investigative Dermatology, 110, pp. 452 - 455, http://dx.doi.org/10.1046/j.1523-1747.1998.00148.x
,1998, 'A novel putative protein-tyrosine phosphate contains a BRO1-like domain and suppresses Ha-ras-mediated transformation', The Journal of Biological Chemistry, pp. 21077 - 21083
,1998, 'Domain-specific gene disruption reveals critical regulation of neuregulin signaling by its cytoplasmic tail', Proceedings of the National Academy of Sciences of the United States of America, pp. 13024 - 13029
,1998, 'Immunohistochemical localisation of alpha(1B)-adrenergic receptors in the rat iris', Cell and Tissue Research, 293, pp. 435 - 444, http://dx.doi.org/10.1007/s004410051135
,1997, 'More supernumeraries?', British dental journal, 183, pp. 49
,